Research & Literature

Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.

Voskamp AL, Gillman A, Symons K, et al.

The journal of allergy and clinical immunology. In practice 2015; (3(2)):192-9.

Acute Invasive Pulmonary Aspergillosis Complicating Allergic Bronchopulmonary Aspergillosis: Case Report and Systematic Review.

Maturu VN, Agarwal R

Mycopathologia 2015; (180(3-4)):209-15 doi:10.1007/s11046-015-9907-0.

Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis.

Maturu VN, Agarwal R

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2015; (45(12)):1765-78 doi:10.1111/cea.12595.

T helper 2 response in allergic bronchopulmonary aspergillosis is not driven by specific Aspergillus antigens.

Jolink H, de Boer R, Willems LN, et al.

Allergy 2015; (70(10)):1336-9 doi:10.1111/all.12688.

High-Attenuation Mucus Impaction in Patients With Allergic Bronchopulmonary Aspergillosis: Objective Criteria on High-Resolution Computed Tomography and Correlation With Serologic Parameters.

Phuyal S, Garg MK, Agarwal R, et al.

Current problems in diagnostic radiology 2016; (45(3)):168-73.

Development of chronic pulmonary aspergillosis in adult asthmatics with ABPA.

Lowes D, Chishimba L, Greaves M, Denning DW

Respiratory medicine 2015; (109(12)):1509-15.

Utility of IgE (total and Aspergillus fumigatus specific) in monitoring for response and exacerbations in allergic bronchopulmonary aspergillosis.

Agarwal R, Aggarwal AN, Sehgal IS, et al.

Mycoses 2016; (59(1)):1-6 doi:10.1111/myc.12423.

A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.

Agarwal R, Aggarwal AN, Dhooria S, et al.

The European respiratory journal 2016; (47(2)):490-8 doi:10.1183/13993003.01475-2015.

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.

Denning DW, Cadranel J, Beigelman-Aubry C, et al.

The European respiratory journal 2016; (47(1)):45-68 doi:10.1183/13993003.00583-2015.

Coexisting atopic conditions influence the likelihood of allergic bronchopulmonary aspergillosis in asthma.

Tay TR, Bosco J, Gillman A, et al.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2016; (117(1)):29-32.e1.

Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease.

Moon SM, Jhun BW, Lee H, et al.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2017; (23(9)):658-660 doi:10.1016/j.jiac.2017.02.004.

Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.

Stott KE, Hope WW

The Journal of antimicrobial chemotherapy 2017; (72(suppl_1)):i12-i18 doi:10.1093/jac/dkx029.

Allergic bronchopulmonary aspergillosis in Japan: A nationwide survey.

Oguma T, Taniguchi M, Shimoda T, et al.

Allergology international : official journal of the Japanese Society of Allergology 2018; (67(1)):79-84 doi:10.1016/j.alit.2017.04.011.

Clinical Analysis of 77 Patients with Allergic Bronchopulmonary Aspergillosis in Peking Union Medical College Hospital.

Zhang M, Gao J

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2017; (39(3)):352-357 doi:10.3881/j.issn.1000-503X.2017.03.009.

A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.

Terashima T, Shinozaki T, Iwami E, et al.

BMC pulmonary medicine 2018; (18(1)):53 doi:10.1186/s12890-018-0617-5.

Itraconazole Dosing and Drug Monitoring at a Tertiary Children's Hospital.

Leong YH, Boast A, Cranswick N, et al.

The Pediatric infectious disease journal 2019; (38(1)):60-64 doi:10.1097/INF.0000000000002048.

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Ashkenazi M, Sity S, Sarouk I, et al.

Journal of asthma and allergy 2018; (11()):101-107 doi:10.2147/JAA.S156049.

A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.

Agarwal R, Dhooria S, Sehgal IS, et al.

The European respiratory journal 2018; (52(3)) doi:10.1183/13993003.01159-2018.

Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy Volunteers.

Abuhelwa AY, Mudge S, Upton RN, Foster DJR

European journal of drug metabolism and pharmacokinetics 2019; (44(2)):201-215 doi:10.1007/s13318-018-0519-1.

Allergic Bronchopulmonary Aspergillosis-A Luminal Hypereosinophilic Disease With Extracellular Trap Cell Death.

Ueki S, Hebisawa A, Kitani M, et al.

Frontiers in immunology 2018; (9()):2346 doi:10.3389/fimmu.2018.02346.

Prevalence of allergic bronchopulmonary aspergillosis in asthmatic patients: A prospective institutional study.

Kalaiyarasan , Jain AK, Puri M, et al.

The Indian journal of tuberculosis 2018; (65(4)):285-289 doi:10.1016/j.ijtb.2018.04.007.

CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis.

Refait J, Macey J, Bui S, et al.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2019; (18(4)):e31-e36 doi:10.1016/j.jcf.2019.02.002.

[Clinical features and reasons for missed diagnosis of allergic bronchopulmonary aspergillosis].

Zou MF, Li S, Yang Y, et al.

Zhonghua yi xue za zhi 2019; (99(16)):1221-1225 doi:10.3760/cma.j.issn.0376-2491.2019.16.006.

Successful treatment with mepolizumab in a case of allergic bronchopulmonary aspergillosis complicated with nontuberculous mycobacterial infection.

Tsubouchi H, Tsuchida S, Yanagi S, et al.

Respiratory medicine case reports 2019; (28()):100875 doi:10.1016/j.rmcr.2019.100875.

Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies.

Nield B, Larsen SR, van Hal SJ

The Journal of antimicrobial chemotherapy 2019; (74(10)):3049-3055 doi:10.1093/jac/dkz303.

Prevalence and Risk Factors of Allergic Bronchopulmonary Aspergillosis and Aspergillus Sensitization in Children with Poorly Controlled Asthma.

Kumari J, Jat KR, Lodha R, et al.

Journal of tropical pediatrics 2020; (66(3)):275-283 doi:10.1093/tropej/fmz066.

The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasis.

Lu HW, Mao B, Wei P, et al.

The clinical respiratory journal 2020; (14(2)):140-147 doi:10.1111/crj.13111.

Successful treatment of allergic bronchopulmonary aspergillosis with posaconazole in a child with cystic fibrosis: Case report and review of the literature.

Yakut N, Kadayifci EK, Eralp EE, Gokdemir Y

Lung India : official organ of Indian Chest Society 2020; (37(2)):161-163 doi:10.4103/lungindia.lungindia_288_19.

Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis.

Gothe F, Schmautz A, Häusler K, et al.

The journal of allergy and clinical immunology. In practice 2020; (8(8)):2608-2614.e3 doi:10.1016/j.jaip.2020.02.031.

Manifestations of pulmonary aspergillosis in pediatrics.

Chacko A, Moss RB

Current opinion in pediatrics 2020; (32(3)):389-394 doi:10.1097/MOP.0000000000000898.

Allergic bronchopulmonary aspergillosis.

Agarwal R, Sehgal IS, Dhooria S, et al.

The Indian journal of medical research 2020; (151(6)):529-549 doi:10.4103/ijmr.IJMR_1187_19.

Allergic bronchopulmonary aspergillosis misdiagnosed as recurrent pneumonia.

Jiang N, Xiang L

Asia Pacific allergy 2020; (10(3)):e27 doi:10.5415/apallergy.2020.10.e27.

Mepolizumab as Possible Treatment for Allergic Bronchopulmonary Aspergillosis: A Review of Eight Cases.

Tolebeyan A, Mohammadi O, Vaezi Z, Amini A

Cureus 2020; (12(8)):e9684 doi:10.7759/cureus.9684.

Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital.

Abbotsford J, Foley DA, Goff Z, et al.

The Journal of antimicrobial chemotherapy 2021; (76(1)):249-252 doi:10.1093/jac/dkaa382.

Current Approach in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis.

Sunman B, Ademhan Tural D, Ozsezen B, et al.

Frontiers in pediatrics 2020; (8()):582964 doi:10.3389/fped.2020.582964.

Mepolizumab use in cystic fibrosis-associated allergic bronchopulmonary aspergillosis.

Boyle M, Mulrennan S, Morey S, et al.

Respirology case reports 2021; (9(1)):e00696 doi:10.1002/rcr2.696.

A Case of Endobronchial Aspergilloma Coexisting With Lung Adenocarcinoma.

El Hage H, Fagel L

Cureus 2020; (12(11)):e11736 doi:10.7759/cureus.11736.

Biomarkers for the Diagnosis of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: A Systematic Review and Meta-Analysis.

Li BCM, Huh SM, Prieto MD, et al.

The journal of allergy and clinical immunology. In practice 2021; (9(5)):1909-1930.e4 doi:10.1016/j.jaip.2020.12.064.

Clinical characteristics of allergic bronchopulmonary aspergillosis in patients with and without bronchiectasis.

Wang S, Zhang J, Zhang C, Shao C

The Journal of asthma : official journal of the Association for the Care of Asthma 2022; (59(6)):1162-1168 doi:10.1080/02770903.2021.1904979.

A retrospective 'real-world' cohort study of azole therapeutic drug monitoring and evolution of antifungal resistance in cystic fibrosis.

Di Paolo M, Hewitt L, Nwanko E, et al.

JAC-antimicrobial resistance 2021; (3(1)):dlab026 doi:10.1093/jacamr/dlab026.

Case Report: Allergic Bronchopulmonary Aspergillosis Revealing Asthma.

Snen H, Kallel A, Blibech H, et al.

Frontiers in immunology 2021; (12()):695954 doi:10.3389/fimmu.2021.695954.

Medical algorithm: Aspergillus fumigatus components in the diagnosis of allergic bronchopulmonary aspergillosis.

Lukaszewicz R, Mahay G, Boyer O, Martinet J

Allergy 2022; (77(1)):327-330 doi:10.1111/all.15001.

Posaconazole-induced hypertension in children with cystic fibrosis.

Marpole R, Yeoh DK, Withers AL

Respirology case reports 2021; (9(9)):e0822 doi:10.1002/rcr2.822.

A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.

Agarwal R, Muthu V, Sehgal IS, et al.

The European respiratory journal 2022; (59(4)) doi:10.1183/13993003.01787-2021.

Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital.

Eldaabossi SAM, Awad A, Anshasi N

Respiratory medicine case reports 2021; (34()):101520 doi:10.1016/j.rmcr.2021.101520.

The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles.

Czyrski A, Resztak M, Świderski P, et al.

Pharmaceutics 2021; (13(11)) doi:10.3390/pharmaceutics13111961.

Clinical Characteristics and Prognosis of Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study.

Zeng Y, Xue X, Cai H, et al.

Journal of asthma and allergy 2022; (15()):53-62 doi:10.2147/JAA.S345427.

A Case of Allergic Bronchopulmonary Aspergillosis With Bronchial Asthma.

Rajpopat PB, Desai BN, Abro S, et al.

Cureus 2022; (14(9)):e29552 doi:10.7759/cureus.29552.

Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis.

Tomomatsu K, Yasuba H, Ishiguro T, et al.

Scientific reports 2023; (13(1)):5468 doi:10.1038/s41598-023-32246-8.

Allergic bronchopulmonary aspergillosis: A multidisciplinary review.

Roboubi A, Audousset C, Fréalle É, et al.

Journal de mycologie medicale 2023; (33(3)):101392 doi:10.1016/j.mycmed.2023.101392.

[Development in diagnostic criteria for allergic bronchopulmonary aspergillosis].

Ma YF, Ma YL, Chen X, et al.

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2023; (46(6)):624-631 doi:10.3760/cma.j.cn112147-20221124-00925.

Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.

McCreary EK, Davis MR, Narayanan N, et al.

Pharmacotherapy 2023; (43(10)):1043-1050 doi:10.1002/phar.2850.

Long-term follow-up of allergic bronchopulmonary aspergillosis treated with glucocorticoids: A study of 182 subjects.

Agarwal R, Sehgal IS, Muthu V, et al.

Mycoses 2023; (66(11)):953-959 doi:10.1111/myc.13640.

Iatrogenic Cushing's syndrome in a case of allergic bronchopulmonary aspergillosis treated with oral itraconazole and inhaled budesonide.

Garg VK, Tickoo V, Prasad VP, Maturu VN

BMJ case reports 2023; (16(10)) doi:10.1136/bcr-2023-256788.

Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis.

Agarwal R, Muthu V, Sehgal IS

Seminars in respiratory and critical care medicine 2024; (45(1)):114-127 doi:10.1055/s-0043-1776912.

Subtherapeutic triazole concentrations as result of a drug-drug interaction with lumacaftor/ivacaftor.

Smeets TJL, van der Sijs H, Janssens HM, et al.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2024; (23(3)):563-565 doi:10.1016/j.jcf.2024.01.006.

Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune.

Oguma T, Ishiguro T, Kamei K, et al.

Clinical and translational allergy 2024; (14(1)):e12327 doi:10.1002/clt2.12327.

High attenuation mucus in bronchi with allergic bronchopulmonary mycosis.

Hattori S, Oguma T, Ishiguro T, et al.

Mycoses 2024; (67(2)):e13705 doi:10.1111/myc.13705.

Sensitivity and specificity of LDBio Aspergillus ICT lateral flow assay for diagnosing allergic bronchopulmonary aspergillosis in adult asthmatics.

Sehgal IS, Muthu V, Dhooria S, et al.

Mycoses 2024; (67(2)):e13700 doi:10.1111/myc.13700.

[Allergic bronchopullmonary aspergillosis (ABPA) - an Update].

Joest M, Klein J, Kütting D, Skowasch D

Pneumologie (Stuttgart, Germany) 2024; (78(3)):204-214 doi:10.1055/a-1854-3006.

Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.

Agarwal R, Sehgal IS, Muthu V, et al.

The European respiratory journal 2024; (63(4)) doi:10.1183/13993003.00061-2024.

Coexistence of Eosinophilic Granulomatosis With Polyangiitis and Allergic Bronchopulmonary Aspergillosis: A Fascinating Relationship.

Marra AM, Curci P, Franco G, et al.

Cureus 2024; (16(4)):e57917 doi:10.7759/cureus.57917.

Interplay of Cytokines and Chemokines in Aspergillosis.

Shankar J, Thakur R, Clemons KV, Stevens DA

Journal of fungi (Basel, Switzerland) 2024; (10(4)) doi:10.3390/jof10040251.

SUBA-itraconazole in the treatment of systemic fungal infections.

Liu J, Vanderwyk KA, Donnelley MA, Thompson Iii GR

Future microbiology 2024; (19(13)):1171-1175 doi:10.1080/17460913.2024.2362128.

Is the Prevalence of Allergic Bronchopulmonary Aspergillosis Greater in Severe Asthma?

Sehgal IS, Saxena P, Dhooria S, et al.

The journal of allergy and clinical immunology. In practice 2024; (12(12)):3269-3273.e1 doi:10.1016/j.jaip.2024.09.002.

EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis.

Sehgal IS, Muthu V, Seidel D, et al.

Mycoses 2024; (67(10)):e13810 doi:10.1111/myc.13810.

A decision tree analysis to evaluate the optimal approach to screen allergic bronchopulmonary aspergillosis in asthmatic patients.

Agarwal R, Sehgal IS, Saxena P, et al.

The Journal of asthma : official journal of the Association for the Care of Asthma 2025; (62(5)):761-766 doi:10.1080/02770903.2024.2439994.

Anti-IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis.

Lamothe PA, Pruett CLH, Smirnova N, et al.

The journal of allergy and clinical immunology. Global 2025; (4(1)):100369 doi:10.1016/j.jacig.2024.100369.

Pulmonary Aspergillus overlap syndrome in a patient with bronchial asthma.

Kunhi Veetil S, Patro M, Gothi D, Pal RS

BMJ case reports 2025; (18(1)) doi:10.1136/bcr-2024-261505.

Allergic Bronchopulmonary Aspergillosis in Patients With Prior Pulmonary Tuberculosis: A Study on the Burden, Clinic-Radiological Features, Treatment Outcomes and Comparison With Chronic Pulmonary Aspergillosis and Post-Tubercular Lung Disease Patients.

Ajayababu A, Meena VP, Sethi P, et al.

Mycoses 2025; (68(2)):e70034 doi:10.1111/myc.70034.

Impact of Bronchiectasis Severity on Clinical Outcomes in Patients With Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study.

Sehgal IS, Muthu V, Dhooria S, et al.

The journal of allergy and clinical immunology. In practice 2025; (13(5)):1103-1109.e2 doi:10.1016/j.jaip.2025.03.005.

2024 imaging criteria for allergic bronchopulmonary aspergillosis: which diagnostic cut-offs? Are chest radiograph and CT comparable?

Dournes G, Benlala I, Berger P

The European respiratory journal 2025; (65(4)) doi:10.1183/13993003.00089-2025.

The Impact of Dietary Interventions on the Pharmacokinetics of Antifungal Drugs: A Systematic Review with Meta-analyses.

Wiesner-Kiełczewska A, Zagrodzki P, Paśko P

Clinical pharmacokinetics 2025; (64(6)):815-848 doi:10.1007/s40262-025-01511-6.

New insights into the treatment of asthma complicated by allergic bronchopulmonary aspergillosis.

Agarwal R, Muthu V, Sehgal IS

Expert review of respiratory medicine 2025; (19(9)):967-979 doi:10.1080/17476348.2025.2517302.

The Triad of Pathogenesis in Allergic Bronchopulmonary Aspergillosis: Interactions among <italic>Aspergillus fumigatus</italic>, Epithelium, and Immunity.

Wang Y, Zhang L, Sun Y, Zhang Y

International archives of allergy and immunology 2025; 1-14 doi:10.1159/000547550.

Association between allergic bronchopulmonary aspergillosis or Aspergillus sensitization and tuberculosis: A systematic review of 607 cases.

Ajayababu A, Hoenigl M, Ray A

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2025; (31(10)):102792 doi:10.1016/j.jiac.2025.102792.

[Late diagnosis of allergic pulmonary aspergillosis in a patient with post-tuberculosis pulmonary sequelae: a fatal case].

Guendulain-Velázquez B

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2025; (72(3)):72 doi:10.29262/ram.v72i3.1504.

Allergic Bronchopulmonary Aspergillosis Presenting as Pyopneumothorax: Expanding the Clinical Spectrum.

Saini JK, Abdullah YV, Modi S, et al.

Annals of African medicine 2026; (25(Suppl 1)):S24-S29 doi:10.4103/aam.aam_452_25.

Allergic bronchopulmonary aspergillosis and Aspergillus-related airway diseases in bronchiectasis: a narrative review.

Agarwal R, Chotirmall SH, Chalmers JD

Journal of thoracic disease 2025; (17(12)):11501-11519 doi:10.21037/jtd-2025-1548.

[Allergic bronchopulmonary aspergillosis-essential knowledge for radiology].

Salhöfer L, Welsner M, Lehmann H, et al.

Radiologie (Heidelberg, Germany) 2026; (66(3)):169-176 doi:10.1007/s00117-026-01567-w.

High total serum IgE level at diagnosis was associated with a progressive decline in lung function in asthmatic patients with allergic bronchopulmonary mycosis.

Kodama Y, Takaoka S, Nakashima T, et al.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2026; (22(1)).

Asthma and Allergic Bronchopulmonary Aspergillosis: Understanding, Insights, and State-of-the-Art.

Saxena P, Muthu V, Sehgal IS, Agarwal R

Journal of inflammation research 2026; (19()):546322 doi:10.2147/JIR.S546322.

[Allergic bronchopulmonary aspergillosis in internal medicine].

Chedal-Anglay C, Martin de Frémont G, Dupin C

La Revue de medecine interne 2026; (47(4)):184-193 doi:10.1016/j.revmed.2026.01.008.

Pharmacist-Led Full-Course Pharmaceutical Care Model in Allergic Bronchopulmonary Aspergillosis: A Case Report-Based Approach to Optimizing Multidisciplinary Management.

Huang X, Zheng Y, Jin X, et al.

Infection and drug resistance 2026; (19()):565067 doi:10.2147/IDR.S565067.

[A case of ABPA in a patient with asthma and bronchiectasis].

Hoxha E, Cocieru A

Pneumologie (Stuttgart, Germany) 2026; doi:10.1055/a-2819-4330.

Does ABPA Contribute to Bronchiectasis? A Structured Evaluation of Competing Hypotheses.

Agarwal R, Sehgal IS, Muthu V, Bardin P

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2026; (56(5)):498-505 doi:10.1111/cea.70299.

Prevalence of allergic bronchopulmonary aspergillosis/Aspergillus sensitization in chronic obstructive pulmonary disease: A systematic review and meta-analysis.

Ajayababu A, Antony A, Goyal B, Ray A

Respiratory investigation 2026; (64(4)):101469 doi:10.1016/j.resinv.2026.101469.